The Endocrine Society has officially announced the appointment of Nanette Santoro, MD, as its president for the 2026–2027 term. Dr.…
A significant proportion of patients prescribed glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes follow a "start-and-stop" pattern of…
The ENDO 2026 annual meeting served as a pivotal platform for the global endocrinology community, unveiling a series of clinical…
The Endocrine Society’s annual meeting, ENDO 2026, convened in Chicago, Illinois, serving as the premier global forum for the latest…
The landscape of modern endocrinology is undergoing a profound transformation, marked by a shift from purely clinical management to a…
In a significant month for the pharmaceutical industry and metabolic medicine, the U.S. Food and Drug Administration (FDA) has issued…
Dr. Teresa K. Woodruff, a world-renowned reproductive scientist and the former president of the Endocrine Society, has been elected to…
The upcoming ENDO 2026 meeting is set to showcase a rare intersection of family legacy and scientific advancement, as Dr.…
The rapid rise of glucagon-like peptide-1 (GLP-1) receptor agonists has transformed the landscape of obesity management, offering unprecedented weight loss…
The American Medical Association (AMA) House of Delegates convened its most recent session in Chicago, Illinois, this past June, bringing…
Amara Maple